On 28 July 2008, Lavipharm Hellas and Pohl Boskamp, a German pharmaceutical company, have entered into a cooperation agreement for the marketing of a pioneer anti-lice product in Greece.

Lavipharm enhanced its successful anti-lice line Laviten, by launching Laviten NYDA. Laviten NYDA is an innovative liquid spray, the composition of which provokes instant death from suffocation to lice, nymphs and nits.

NYDA is already marketed in Germany, France, Great Britain, the Netherlands, Austria, Finland, Poland and Lithuania, marking great success, while other countries are scheduled to follow soon.

Read more: http://www.lavipharm.gr/english/contact/index.asp?section=news&art_id=376

Or return to the HBio news page